SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-004836
Filing Date
2022-02-04
Accepted
2022-02-04 16:40:10
Documents
1
Period of Report
2022-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4181
  Complete submission text file 0000899243-22-004836.txt   5587
Mailing Address C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
BRYCE RICHARD PAUL (Reporting) CIK: 0001553037 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40356 | Film No.: 22594016

Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Therapeutics Inc. (Issuer) CIK: 0001724979 (see all company filings)

IRS No.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations